• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PAGE-B 和 REACH-B 可预测巴西东北部慢性乙型肝炎患者发生肝细胞癌的风险。

PAGE-B and REACH-B Predicts the Risk of Developing Hepatocellular Carcinoma in Chronic Hepatitis B Patients from Northeast, Brazil.

机构信息

Center for Liver Studies, University Hospital of the Federal University of Maranhão, Saint Louis CEP 65020-070, MA, Brazil.

Federal University of Maranhão, Medicine Course, Saint Louis CEP 65020-070, MA, Brazil.

出版信息

Viruses. 2022 Mar 31;14(4):732. doi: 10.3390/v14040732.

DOI:10.3390/v14040732
PMID:35458462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9033073/
Abstract

This study aims to evaluate the accuracy of the PAGE-B and REACH-B scores in predicting the risk of developing HCC in patients with chronic hepatitis B regularly followed up at a reference service in the State of Maranhão. A historical, longitudinal, retrospective cohort study, carried out from the review of medical records of patients with chronic Hepatitis B. PAGE-B and REACH-B scores were calculated and the accuracy of the scores in predicting the risk of HCC in the studied population was evaluated. A total of 978 patients were included, with a median age of around 47 years, most of them female and not cirrhotic. HCC was identified in 34 patients. Thrombocytopenia, high viral load, male gender and age were associated with the occurrence of HCC. The ROC curve for the PAGE-B score showed a value of 0.78 and for the REACH-B score of 0.79. The cutoff point for PAGE-B was 11 points for greater sensitivity and for REACH-B 7.5 points considering greater sensitivity and 9.5 points considering greater specificity. PAGE-B and REACH-B scores were able to predict the risk of developing HCC in the studied population. The use of risk stratification scores is useful to reduce costs associated with HCC screening.

摘要

本研究旨在评估 PAGE-B 和 REACH-B 评分在预测定期在马腊尼昂州参考服务机构接受慢性乙型肝炎随访的患者发生 HCC 的风险中的准确性。这是一项历史的、纵向的、回顾性队列研究,通过对慢性乙型肝炎患者的病历进行回顾。计算了 PAGE-B 和 REACH-B 评分,并评估了评分在预测研究人群中 HCC 风险中的准确性。共纳入 978 例患者,中位年龄约为 47 岁,大多数为女性且无肝硬化。34 例患者发生 HCC。血小板减少、高病毒载量、男性和年龄与 HCC 的发生有关。PAGE-B 评分的 ROC 曲线值为 0.78,REACH-B 评分的 ROC 曲线值为 0.79。PAGE-B 的截断值为 11 分,以提高敏感性,而 REACH-B 的截断值为 7.5 分,以提高敏感性,9.5 分以提高特异性。PAGE-B 和 REACH-B 评分能够预测研究人群中 HCC 的发生风险。风险分层评分的使用有助于降低与 HCC 筛查相关的成本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879d/9033073/8661c99dd6b7/viruses-14-00732-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879d/9033073/bcb52dc58670/viruses-14-00732-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879d/9033073/d8e1b551ae8d/viruses-14-00732-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879d/9033073/e90611b7f6d5/viruses-14-00732-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879d/9033073/8661c99dd6b7/viruses-14-00732-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879d/9033073/bcb52dc58670/viruses-14-00732-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879d/9033073/d8e1b551ae8d/viruses-14-00732-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879d/9033073/e90611b7f6d5/viruses-14-00732-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879d/9033073/8661c99dd6b7/viruses-14-00732-g004.jpg

相似文献

1
PAGE-B and REACH-B Predicts the Risk of Developing Hepatocellular Carcinoma in Chronic Hepatitis B Patients from Northeast, Brazil.PAGE-B 和 REACH-B 可预测巴西东北部慢性乙型肝炎患者发生肝细胞癌的风险。
Viruses. 2022 Mar 31;14(4):732. doi: 10.3390/v14040732.
2
Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B.重新评估与PAGE-B相关的评分预测慢性乙型肝炎患者肝细胞癌发生的准确性。
J Hepatol. 2020 May;72(5):847-854. doi: 10.1016/j.jhep.2019.12.005. Epub 2019 Dec 16.
3
Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment.PAGE-B评分对接受治疗的白种人慢性乙型肝炎患者肝细胞癌风险预测的验证
World J Gastroenterol. 2022 Feb 14;28(6):665-674. doi: 10.3748/wjg.v28.i6.665.
4
External validation of hepatocellular carcinoma risk scores in patients with chronic hepatitis B virus infection in China.在中国慢性乙型肝炎病毒感染者中对肝细胞癌风险评分进行外部验证。
J Viral Hepat. 2021 Oct;28(10):1373-1380. doi: 10.1111/jvh.13569. Epub 2021 Jul 22.
5
Evaluation of the Hepatocellular Carcinoma Predictive Scores PAGE-B and mPAGE-B among Brazilian Patients with Chronic Hepatitis B Virus Infection.评估 PAGE-B 和 mPAGE-B 肝癌预测评分在巴西慢性乙型肝炎病毒感染患者中的应用。
Viruses. 2022 Sep 5;14(9):1968. doi: 10.3390/v14091968.
6
Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment.慢性乙型肝炎患者接受恩替卡韦治疗的风险评分的准确性。
Gastroenterology. 2013 May;144(5):933-44. doi: 10.1053/j.gastro.2013.02.002. Epub 2013 Feb 12.
7
Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment.动态评估核苷酸/核苷类似物治疗慢性乙型肝炎患者肝细胞癌预测模型。
J Viral Hepat. 2021 May;28(5):787-794. doi: 10.1111/jvh.13473. Epub 2021 Feb 10.
8
Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B.慢性乙型肝炎中肝细胞癌风险评分的临床应用
Liver Int. 2020 Mar;40(3):484-495. doi: 10.1111/liv.14334. Epub 2020 Jan 7.
9
Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B.接受口服抗病毒治疗的初治慢性乙型肝炎患者发生肝细胞癌的风险评分模型
Clin Mol Hepatol. 2017 Jun;23(2):170-178. doi: 10.3350/cmh.2016.0086. Epub 2017 May 16.
10
Verification of hepatitis B-related hepatocellular carcinoma predictive models to evaluate the risk of HCC in patients with liver cirrhosis under antiviral treatment.验证乙型肝炎相关肝细胞癌预测模型,以评估抗病毒治疗下肝硬化患者 HCC 的风险。
Eur J Gastroenterol Hepatol. 2022 May 1;34(5):546-552. doi: 10.1097/MEG.0000000000002302.

引用本文的文献

1
The Cost-Effectiveness of Tenofovir Alafenamide for Chronic Hepatitis B Virus in Taiwan.替诺福韦艾拉酚胺治疗台湾慢性乙型肝炎病毒感染的成本效益分析
MDM Policy Pract. 2025 Mar 29;10(1):23814683251328659. doi: 10.1177/23814683251328659. eCollection 2025 Jan-Jun.
2
Evaluating the predictive value of clinical models for HBV-related hepatocellular carcinoma: A meta-analysis.评估乙肝相关肝细胞癌临床模型的预测价值:一项荟萃分析。
Front Med (Lausanne). 2025 Feb 21;12:1529201. doi: 10.3389/fmed.2025.1529201. eCollection 2025.
3
Comparison of models to predict incident chronic liver disease: a systematic review and external validation in Chinese adults.

本文引用的文献

1
Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B.基于 PAGE-B 风险评分指导的慢性乙型肝炎治疗后 HCC 监测的成本评估。
BMC Health Serv Res. 2021 Aug 21;21(1):846. doi: 10.1186/s12913-021-06794-6.
2
Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients.慢性乙型肝炎患者肝细胞癌发生的预测模型
World J Clin Cases. 2021 May 16;9(14):3238-3251. doi: 10.12998/wjcc.v9.i14.3238.
3
Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External Validation.
预测新发慢性肝病模型的比较:一项针对中国成年人的系统评价与外部验证
BMC Med. 2024 Dec 31;22(1):601. doi: 10.1186/s12916-024-03754-9.
4
Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine.肝硬化:中西医治疗现状与选择
Front Pharmacol. 2024 Jul 16;15:1381476. doi: 10.3389/fphar.2024.1381476. eCollection 2024.
5
Evaluation of PAGE-B Score for Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients: Reliability, Validity, and Responsiveness.慢性乙型肝炎患者肝细胞癌发生的PAGE - B评分评估:可靠性、有效性和反应性
Biomedicines. 2024 Jun 5;12(6):1260. doi: 10.3390/biomedicines12061260.
6
Liver Carcinogenesis Suppression in Chronic Hepatitis B in the Nucleoside Analogues Era.核苷类似物时代慢性乙型肝炎的肝癌发生抑制。
In Vivo. 2024 Jan-Feb;38(1):40-47. doi: 10.21873/invivo.13408.
7
Serum protein biomarkers for HCC risk prediction in HIV/HBV co-infected people: a clinical proteomic study using mass spectrometry.血清蛋白质生物标志物可预测 HIV/HBV 共感染人群的 HCC 风险:一项使用质谱的临床蛋白质组学研究。
Front Immunol. 2023 Nov 10;14:1282469. doi: 10.3389/fimmu.2023.1282469. eCollection 2023.
8
HIV-HBV Coinfection-Current Challenges for Virologic Monitoring.HIV-HBV合并感染——病毒学监测的当前挑战
Biomedicines. 2023 Apr 28;11(5):1306. doi: 10.3390/biomedicines11051306.
9
Evaluation of the Hepatocellular Carcinoma Predictive Scores PAGE-B and mPAGE-B among Brazilian Patients with Chronic Hepatitis B Virus Infection.评估 PAGE-B 和 mPAGE-B 肝癌预测评分在巴西慢性乙型肝炎病毒感染患者中的应用。
Viruses. 2022 Sep 5;14(9):1968. doi: 10.3390/v14091968.
慢性乙型肝炎肝细胞癌预测模型:14 个模型的系统评价和外部验证。
Clin Gastroenterol Hepatol. 2021 Dec;19(12):2499-2513. doi: 10.1016/j.cgh.2021.02.040. Epub 2021 Mar 3.
4
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.亚太肝脏研究学会慢性乙型肝炎病毒风险评分在口服抗病毒治疗的慢性乙型肝炎患者中预测肝细胞癌的真实世界疗效。
J Infect Dis. 2020 Jan 14;221(3):389-399. doi: 10.1093/infdis/jiz477.
5
Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir.接受恩替卡韦/替诺福韦治疗的初治慢性乙型肝炎患者肝细胞癌风险预测模型。
Eur J Gastroenterol Hepatol. 2019 Jul;31(7):865-872. doi: 10.1097/MEG.0000000000001357.
6
Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy.改良 PAGE-B 评分可预测接受抗病毒治疗的亚洲慢性乙型肝炎患者发生肝细胞癌的风险。
J Hepatol. 2018 Nov;69(5):1066-1073. doi: 10.1016/j.jhep.2018.07.018. Epub 2018 Aug 1.
7
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.符合肝细胞癌监测指南与代偿性病毒肝硬化患者的生存时间延长相关:一项多中心队列研究。
Gastroenterology. 2018 Aug;155(2):431-442.e10. doi: 10.1053/j.gastro.2018.04.027. Epub 2018 May 3.
8
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南:肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
9
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.开发一种评分系统,以预测亚洲慢性乙型肝炎抗病毒治疗患者的肝细胞癌。
J Hepatol. 2018 Aug;69(2):278-285. doi: 10.1016/j.jhep.2018.02.032. Epub 2018 Mar 16.
10
Prediction of long-term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE-B score.不同慢性乙型肝炎人群长期临床结局的预测:PAGE-B评分的作用。
J Viral Hepat. 2017 Nov;24(11):1023-1031. doi: 10.1111/jvh.12727. Epub 2017 Jul 22.